Chlamydia pneumoniae and coronary artery disease: legitimized linkages?
Chlamydia pneumoniae (Cp) infection in early life may accelerate atherosclerosis over ensuing decades, leading to cardiovascular complications. Cp promotes endothelial dysfunction and may modulate inflammation underlying atherosclerosis. It represents a biologically plausible candidate for the causa...
Gespeichert in:
| Veröffentlicht in: | Expert review of cardiovascular therapy 2003-10, Vol.1 (3), p.367-384 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 384 |
|---|---|
| container_issue | 3 |
| container_start_page | 367 |
| container_title | Expert review of cardiovascular therapy |
| container_volume | 1 |
| creator | Higgins, John P Higgins, Johanna A Higgins, Patricia M Ahuja, Samir Higgins, Daniel L |
| description | Chlamydia pneumoniae (Cp) infection in early life may accelerate atherosclerosis over ensuing decades, leading to cardiovascular complications. Cp promotes endothelial dysfunction and may modulate inflammation underlying atherosclerosis. It represents a biologically plausible candidate for the causation of atherosclerosis. Other infections simultaneously occurring with Cp may result in a synergistic effect to promote atherosclerosis. Studies on the treatment of Cp with antibiotics indicates decreased rates of infection, modulation of inflammation and in some settings, fewer cardiovascular complications. |
| doi_str_mv | 10.1586/14779072.1.3.367 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_902103706</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A236248913</galeid><sourcerecordid>A236248913</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-774996178b70d756b5744ef453b781adcc5aa36b6a413cc3bf7f59d5b67b02623</originalsourceid><addsrcrecordid>eNqNks2L1DAYxoso7rp69yRFYfHSmu-0uwcZBl2FBS96Dm_TdCZrmoxJi4x__abMyKroIjm8Ifk970fyFMVzjGrMG_EGMylbJEmNa1pTIR8Up1gyVjWUsYd5n6-r5f6keJLSDUKUtZw-Lk4wRxQRwU-Lq_XWwbjvLZQ7b-YxeAumBN-XOsTgIe5LiJPJobfJQDIXpTMbO9nR_jB96az_ChuT3j4tHg3gknl2jGfFl_fvPq8_VNefrj6uV9eVZpRMlZSsbQWWTSdRL7noeG7XDIzTTjYYeq05ABWdAIap1rQb5MDbnndCdrlhQs-K80PeXQzfZpMmNdqkjXPgTZiTkpgLwjHO4Ot7QUwajhrJ-IK-_AO9CXP0eQzVIoIRlUhk6NUB2oAzyvohTBH0klOtCBWENS2mmar_QuXVm9Hq4M1g8_mKSCIkasT_C36pgA4CHUNK0QxqF-2Y_0lhpBZTqJ-mUFhRlU2RJS-O883daPo7wdEFGbg8AEv9OML3EF2vJti7EIcIXtuk6D3pL35Tbw24aashmrt3_Kf4FtXK1DY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>902103706</pqid></control><display><type>article</type><title>Chlamydia pneumoniae and coronary artery disease: legitimized linkages?</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Higgins, John P ; Higgins, Johanna A ; Higgins, Patricia M ; Ahuja, Samir ; Higgins, Daniel L</creator><creatorcontrib>Higgins, John P ; Higgins, Johanna A ; Higgins, Patricia M ; Ahuja, Samir ; Higgins, Daniel L</creatorcontrib><description>Chlamydia pneumoniae (Cp) infection in early life may accelerate atherosclerosis over ensuing decades, leading to cardiovascular complications. Cp promotes endothelial dysfunction and may modulate inflammation underlying atherosclerosis. It represents a biologically plausible candidate for the causation of atherosclerosis. Other infections simultaneously occurring with Cp may result in a synergistic effect to promote atherosclerosis. Studies on the treatment of Cp with antibiotics indicates decreased rates of infection, modulation of inflammation and in some settings, fewer cardiovascular complications.</description><identifier>ISSN: 1477-9072</identifier><identifier>EISSN: 1744-8344</identifier><identifier>DOI: 10.1586/14779072.1.3.367</identifier><identifier>PMID: 15030265</identifier><language>eng</language><publisher>England: Informa Healthcare</publisher><subject>Antibiotics ; Arteriosclerosis ; Atherosclerosis ; Bacterial pneumonia ; Care and treatment ; Causality ; Chlamydia ; Chlamydia infections ; Chlamydia pneumoniae ; Chlamydophila Infections - complications ; Chlamydophila pneumoniae ; Complications and side effects ; Coronary Artery Disease - etiology ; Coronary heart disease ; Drug therapy ; Health aspects ; Heart diseases ; Humans ; Infection ; Inflammation ; pathogen burden ; Pneumonia ; Research Design ; Reviews ; Risk factors</subject><ispartof>Expert review of cardiovascular therapy, 2003-10, Vol.1 (3), p.367-384</ispartof><rights>1993 Harwood Academic Publishers GmbH Printed in the United States of America 1993</rights><rights>COPYRIGHT 2003 Taylor & Francis Group LLC</rights><rights>COPYRIGHT 2003 Expert Reviews Ltd.</rights><rights>Copyright Expert Reviews Ltd. Oct 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c432t-774996178b70d756b5744ef453b781adcc5aa36b6a413cc3bf7f59d5b67b02623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15030265$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Higgins, John P</creatorcontrib><creatorcontrib>Higgins, Johanna A</creatorcontrib><creatorcontrib>Higgins, Patricia M</creatorcontrib><creatorcontrib>Ahuja, Samir</creatorcontrib><creatorcontrib>Higgins, Daniel L</creatorcontrib><title>Chlamydia pneumoniae and coronary artery disease: legitimized linkages?</title><title>Expert review of cardiovascular therapy</title><addtitle>Expert Rev Cardiovasc Ther</addtitle><description>Chlamydia pneumoniae (Cp) infection in early life may accelerate atherosclerosis over ensuing decades, leading to cardiovascular complications. Cp promotes endothelial dysfunction and may modulate inflammation underlying atherosclerosis. It represents a biologically plausible candidate for the causation of atherosclerosis. Other infections simultaneously occurring with Cp may result in a synergistic effect to promote atherosclerosis. Studies on the treatment of Cp with antibiotics indicates decreased rates of infection, modulation of inflammation and in some settings, fewer cardiovascular complications.</description><subject>Antibiotics</subject><subject>Arteriosclerosis</subject><subject>Atherosclerosis</subject><subject>Bacterial pneumonia</subject><subject>Care and treatment</subject><subject>Causality</subject><subject>Chlamydia</subject><subject>Chlamydia infections</subject><subject>Chlamydia pneumoniae</subject><subject>Chlamydophila Infections - complications</subject><subject>Chlamydophila pneumoniae</subject><subject>Complications and side effects</subject><subject>Coronary Artery Disease - etiology</subject><subject>Coronary heart disease</subject><subject>Drug therapy</subject><subject>Health aspects</subject><subject>Heart diseases</subject><subject>Humans</subject><subject>Infection</subject><subject>Inflammation</subject><subject>pathogen burden</subject><subject>Pneumonia</subject><subject>Research Design</subject><subject>Reviews</subject><subject>Risk factors</subject><issn>1477-9072</issn><issn>1744-8344</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNks2L1DAYxoso7rp69yRFYfHSmu-0uwcZBl2FBS96Dm_TdCZrmoxJi4x__abMyKroIjm8Ifk970fyFMVzjGrMG_EGMylbJEmNa1pTIR8Up1gyVjWUsYd5n6-r5f6keJLSDUKUtZw-Lk4wRxQRwU-Lq_XWwbjvLZQ7b-YxeAumBN-XOsTgIe5LiJPJobfJQDIXpTMbO9nR_jB96az_ChuT3j4tHg3gknl2jGfFl_fvPq8_VNefrj6uV9eVZpRMlZSsbQWWTSdRL7noeG7XDIzTTjYYeq05ABWdAIap1rQb5MDbnndCdrlhQs-K80PeXQzfZpMmNdqkjXPgTZiTkpgLwjHO4Ot7QUwajhrJ-IK-_AO9CXP0eQzVIoIRlUhk6NUB2oAzyvohTBH0klOtCBWENS2mmar_QuXVm9Hq4M1g8_mKSCIkasT_C36pgA4CHUNK0QxqF-2Y_0lhpBZTqJ-mUFhRlU2RJS-O883daPo7wdEFGbg8AEv9OML3EF2vJti7EIcIXtuk6D3pL35Tbw24aashmrt3_Kf4FtXK1DY</recordid><startdate>20031001</startdate><enddate>20031001</enddate><creator>Higgins, John P</creator><creator>Higgins, Johanna A</creator><creator>Higgins, Patricia M</creator><creator>Ahuja, Samir</creator><creator>Higgins, Daniel L</creator><general>Informa Healthcare</general><general>Taylor & Francis</general><general>Taylor & Francis Group LLC</general><general>Expert Reviews Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20031001</creationdate><title>Chlamydia pneumoniae and coronary artery disease: legitimized linkages?</title><author>Higgins, John P ; Higgins, Johanna A ; Higgins, Patricia M ; Ahuja, Samir ; Higgins, Daniel L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-774996178b70d756b5744ef453b781adcc5aa36b6a413cc3bf7f59d5b67b02623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Antibiotics</topic><topic>Arteriosclerosis</topic><topic>Atherosclerosis</topic><topic>Bacterial pneumonia</topic><topic>Care and treatment</topic><topic>Causality</topic><topic>Chlamydia</topic><topic>Chlamydia infections</topic><topic>Chlamydia pneumoniae</topic><topic>Chlamydophila Infections - complications</topic><topic>Chlamydophila pneumoniae</topic><topic>Complications and side effects</topic><topic>Coronary Artery Disease - etiology</topic><topic>Coronary heart disease</topic><topic>Drug therapy</topic><topic>Health aspects</topic><topic>Heart diseases</topic><topic>Humans</topic><topic>Infection</topic><topic>Inflammation</topic><topic>pathogen burden</topic><topic>Pneumonia</topic><topic>Research Design</topic><topic>Reviews</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Higgins, John P</creatorcontrib><creatorcontrib>Higgins, Johanna A</creatorcontrib><creatorcontrib>Higgins, Patricia M</creatorcontrib><creatorcontrib>Ahuja, Samir</creatorcontrib><creatorcontrib>Higgins, Daniel L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Expert review of cardiovascular therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Higgins, John P</au><au>Higgins, Johanna A</au><au>Higgins, Patricia M</au><au>Ahuja, Samir</au><au>Higgins, Daniel L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chlamydia pneumoniae and coronary artery disease: legitimized linkages?</atitle><jtitle>Expert review of cardiovascular therapy</jtitle><addtitle>Expert Rev Cardiovasc Ther</addtitle><date>2003-10-01</date><risdate>2003</risdate><volume>1</volume><issue>3</issue><spage>367</spage><epage>384</epage><pages>367-384</pages><issn>1477-9072</issn><eissn>1744-8344</eissn><abstract>Chlamydia pneumoniae (Cp) infection in early life may accelerate atherosclerosis over ensuing decades, leading to cardiovascular complications. Cp promotes endothelial dysfunction and may modulate inflammation underlying atherosclerosis. It represents a biologically plausible candidate for the causation of atherosclerosis. Other infections simultaneously occurring with Cp may result in a synergistic effect to promote atherosclerosis. Studies on the treatment of Cp with antibiotics indicates decreased rates of infection, modulation of inflammation and in some settings, fewer cardiovascular complications.</abstract><cop>England</cop><pub>Informa Healthcare</pub><pmid>15030265</pmid><doi>10.1586/14779072.1.3.367</doi><tpages>18</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1477-9072 |
| ispartof | Expert review of cardiovascular therapy, 2003-10, Vol.1 (3), p.367-384 |
| issn | 1477-9072 1744-8344 |
| language | eng |
| recordid | cdi_proquest_journals_902103706 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Antibiotics Arteriosclerosis Atherosclerosis Bacterial pneumonia Care and treatment Causality Chlamydia Chlamydia infections Chlamydia pneumoniae Chlamydophila Infections - complications Chlamydophila pneumoniae Complications and side effects Coronary Artery Disease - etiology Coronary heart disease Drug therapy Health aspects Heart diseases Humans Infection Inflammation pathogen burden Pneumonia Research Design Reviews Risk factors |
| title | Chlamydia pneumoniae and coronary artery disease: legitimized linkages? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T05%3A27%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chlamydia%20pneumoniae%20and%20coronary%20artery%20disease:%20legitimized%20linkages?&rft.jtitle=Expert%20review%20of%20cardiovascular%20therapy&rft.au=Higgins,%20John%20P&rft.date=2003-10-01&rft.volume=1&rft.issue=3&rft.spage=367&rft.epage=384&rft.pages=367-384&rft.issn=1477-9072&rft.eissn=1744-8344&rft_id=info:doi/10.1586/14779072.1.3.367&rft_dat=%3Cgale_proqu%3EA236248913%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=902103706&rft_id=info:pmid/15030265&rft_galeid=A236248913&rfr_iscdi=true |